Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Frank Spillmann

Showing results (31-40 of 59) with videos related to

Pageof 6
Sort By:
Circulation|April 17, 2008
Role of left ventricular stiffness in heart failure with normal ejection fractionDirk Westermann, Mario Kasner, Paul Steendijk, et al.
Regenerative Medicine|May 1, 2007
Regional and global protective effects of tissue kallikrein gene delivery to the peri-infarct myocardiumFrank Spillmann, Gallia Graiani, Sophie Van Linthout, et al.
European Journal of Pharmacology|September 6, 2005
Protection against oxidative stress in diabetic rats: role of angiotensin AT(1) receptor and beta 1-adrenoceptor antagonismMarc Dorenkamp, Alexander Riad, Sebastian Stiehl, et al.
Hypertension (Dallas, Tex. : 1979)|March 11, 2009
Vascular-protective effects of high-density lipoprotein include the downregulation of the angiotensin II type 1 receptorSophie Van Linthout, Frank Spillmann, Mario Lorenz, et al.
Hypertension (Dallas, Tex. : 1979)|July 7, 2005
Genetic deletion of the p66Shc adaptor protein protects from angiotensin II-induced myocardial damageGallia Graiani, Costanza Lagrasta, Enrica Migliaccio, et al.
European Journal of Pharmacology|October 7, 2006
Cardiac function and remodeling is attenuated in transgenic rats expressing the human kallikrein-1 gene after myocardial infarctionMatthias Koch, Frank Spillmann, Andreas Dendorfer, et al.
ESC Heart Failure|February 18, 2022
Colchicine prevents disease progression in viral myocarditis via modulating the NLRP3 inflammasome in the cardiosplenic axisKathleen Pappritz, Jie Lin, Muhammad El-Shafeey, et al.
FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology|May 1, 2004
Prevention of cardiac fibrosis and left ventricular dysfunction in diabetic cardiomyopathy in rats by transgenic expression of the human tissue kallikrein geneCarsten Tschöpe, Thomas Walther, Jens Königer, et al.
International Journal of Cardiology|December 7, 2015
Cardiac contractility modulation signals improve exercise intolerance and maladaptive regulation of cardiac key proteins for systolic and diastolic function in HFpEFCarsten Tschöpe, Sophie Van Linthout, Frank Spillmann, et al.
FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology|September 1, 2005
Transgenic activation of the kallikrein-kinin system inhibits intramyocardial inflammation, endothelial dysfunction and oxidative stress in experimental diabetic cardiomyopathyCarsten Tschöpe, Thomas Walther, Felicitas Escher, et al.
Pageof 6

Showing results (31-40 of 59) with videos related to

Sort By:
Pageof 6
Circulation|April 17, 2008
Role of left ventricular stiffness in heart failure with normal ejection fractionDirk Westermann, Mario Kasner, Paul Steendijk, et al.
Regenerative Medicine|May 1, 2007
Regional and global protective effects of tissue kallikrein gene delivery to the peri-infarct myocardiumFrank Spillmann, Gallia Graiani, Sophie Van Linthout, et al.
European Journal of Pharmacology|September 6, 2005
Protection against oxidative stress in diabetic rats: role of angiotensin AT(1) receptor and beta 1-adrenoceptor antagonismMarc Dorenkamp, Alexander Riad, Sebastian Stiehl, et al.
Hypertension (Dallas, Tex. : 1979)|March 11, 2009
Vascular-protective effects of high-density lipoprotein include the downregulation of the angiotensin II type 1 receptorSophie Van Linthout, Frank Spillmann, Mario Lorenz, et al.
Hypertension (Dallas, Tex. : 1979)|July 7, 2005
Genetic deletion of the p66Shc adaptor protein protects from angiotensin II-induced myocardial damageGallia Graiani, Costanza Lagrasta, Enrica Migliaccio, et al.
European Journal of Pharmacology|October 7, 2006
Cardiac function and remodeling is attenuated in transgenic rats expressing the human kallikrein-1 gene after myocardial infarctionMatthias Koch, Frank Spillmann, Andreas Dendorfer, et al.
ESC Heart Failure|February 18, 2022
Colchicine prevents disease progression in viral myocarditis via modulating the NLRP3 inflammasome in the cardiosplenic axisKathleen Pappritz, Jie Lin, Muhammad El-Shafeey, et al.
FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology|May 1, 2004
Prevention of cardiac fibrosis and left ventricular dysfunction in diabetic cardiomyopathy in rats by transgenic expression of the human tissue kallikrein geneCarsten Tschöpe, Thomas Walther, Jens Königer, et al.
International Journal of Cardiology|December 7, 2015
Cardiac contractility modulation signals improve exercise intolerance and maladaptive regulation of cardiac key proteins for systolic and diastolic function in HFpEFCarsten Tschöpe, Sophie Van Linthout, Frank Spillmann, et al.
FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology|September 1, 2005
Transgenic activation of the kallikrein-kinin system inhibits intramyocardial inflammation, endothelial dysfunction and oxidative stress in experimental diabetic cardiomyopathyCarsten Tschöpe, Thomas Walther, Felicitas Escher, et al.
Pageof 6